PubMed

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. Epub 2009 May 26.PMID: 19470930 [PubMed - indexed for MEDLINE]Related articles

Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program.

Shields CG, Morrow GR, Griggs J, Mallinger J, Roscoe J, Wade JL, Dakhil SR, Fitch TR.

Support Cancer Ther. 2004 Jan 1;1(2):119-26.PMID: 18628188 [PubMed - in process]Related articlesFree article

Evaluation of fulvestrant in clinical practice: use of an electronic data registry.

Lower EE, Esparaz BT, Garnett SA, Wade JL 3rd.

Clin Breast Cancer. 2007 Apr;7(7):565-9.PMID: 17509166 [PubMed - indexed for MEDLINE]Related articles

A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.

Posadas EM, Undevia S, Manchen E, Wade JL, Colevas AD, Karrison T, Vokes EE, Stadler WM.

Cancer Biol Ther. 2007 Apr;6(4):490-3.PMID: 17457044 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.

Choong NW, Mauer AM, Hoffman PC, Rudin CM, Winegarden JD 3rd, Villano JL, Kozloff M, Wade JL 3rd, Sciortino DF, Szeto L, Vokes EE.

J Thorac Oncol. 2006 Mar;1(3):245-51.PMID: 17409864 [PubMed - indexed for MEDLINE]Related articles

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, Taplin M, Vogelzang NJ, Wade JL 3rd, Bennett CL, Scher HI; American Society of Clinical Oncology.

J Clin Oncol. 2007 Apr 20;25(12):1596-605. Epub 2007 Apr 2. Review.PMID: 17404365 [PubMed - indexed for MEDLINE]Related articles

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee M, Pajon ER, Wade JL 3rd, Dakhil S, Lockhart JB Jr, Wolmark N, Ganz PA.

JAMA. 2006 Jun 21;295(23):2742-51. Epub 2006 Jun 5. Erratum in: JAMA. 2007 Sep 5;298(9):973. PMID: 16754728 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL 3rd, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N; National Surgical Adjuvant Breast and Bowel Project (NSABP).

JAMA. 2006 Jun 21;295(23):2727-41. Epub 2006 Jun 5. Erratum in: JAMA. 2006 Dec 27;296(24):2926. JAMA. 2007 Sep 5;298(9):973. PMID: 16754727 [PubMed - indexed for MEDLINE]Related articlesFree article

Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected.

Roscoe JA, Jean-Pierre P, Morrow GR, Hickok JT, Issell B, Wade JL, King DK.

J Soc Integr Oncol. 2006 Winter;4(1):16-20.PMID: 16737668 [PubMed - indexed for MEDLINE]Related articles

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC.

J Clin Oncol. 2006 Jul 1;24(19):3187-205. Epub 2006 May 8.PMID: 16682719 [PubMed - indexed for MEDLINE]Related articles

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study.

Macdonald JS, McCoy S, Whitehead RP, Iqbal S, Wade JL 3rd, Giguere JK, Abbruzzese JL.

Invest New Drugs. 2005 Oct;23(5):485-7.PMID: 16133800 [PubMed - indexed for MEDLINE]Related articles

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998).

Wiernik PH, Paietta E, Goloubeva O, Lee SJ, Makower D, Bennett JM, Wade JL, Ghosh C, Kaminer LS, Pizzolo J, Tallman MS; Eastern Cooperative Oncology Group.

Leukemia. 2004 Oct;18(10):1605-10.PMID: 15356646 [PubMed - indexed for MEDLINE]Related articles

Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices.

Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL, Fitch TR.

Cancer. 2004 Aug 15;101(4):851-7.PMID: 15305419 [PubMed - indexed for MEDLINE]Related articlesFree article

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

Loblaw DA, Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL Jr, Bennett CL, Scher HI; American Society of Clinical Oncology.

J Clin Oncol. 2004 Jul 15;22(14):2927-41. Epub 2004 Jun 7. Erratum in: J Clin Oncol. 2004 Nov 1;22(21):4435. PMID: 15184404 [PubMed - indexed for MEDLINE]Related articles

Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.

Rivera E, Valero V, Arun B, Royce M, Adinin R, Hoelzer K, Walters R, Wade JL 3rd, Pusztai L, Hortobagyi GN.

J Clin Oncol. 2003 Sep 1;21(17):3249-54.PMID: 12947059 [PubMed - indexed for MEDLINE]Related articles

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.

Seidenfeld J, Piper M, Flamm C, Hasselblad V, Armitage JO, Bennett CL, Gordon MS, Lichtin AE, Wade JL 3rd, Woolf S, Aronson N.

J Natl Cancer Inst. 2001 Aug 15;93(16):1204-14.PMID: 11504766 [PubMed - indexed for MEDLINE]Related articlesFree article

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.

Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL 3rd, Winn RJ, Wozniak AJ, Somerfield MR; American Society of Clinical Oncology.

J Clin Oncol. 2000 Oct 15;18(20):3558-85. No abstract available. PMID: 11032599 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia.

Kucuk O, Kilton L, Wade JL, Blough R, Benson AB 3rd.

Am J Clin Oncol. 2000 Aug;23(4):379-83.PMID: 10955868 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Rini BI, Vogelzang NJ, Dumas MC, Wade JL 3rd, Taber DA, Stadler WM.

J Clin Oncol. 2000 Jun;18(12):2419-26.PMID: 10856102 [PubMed - indexed for MEDLINE]Related articles

Effect of managed care on community oncology clinical practice and research.

Wade JL 3rd.

Cancer Invest. 1999;17(7):535-42. Review. No abstract available. PMID: 10518197 [PubMed - indexed for MEDLINE]Related articles

Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study.

Kraut EH, Crowley JJ, Wade JL, Laufman LR, Alsina M, Taylor SA, Salmon SE.

J Clin Oncol. 1998 Feb;16(2):589-92.PMID: 9469346 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.

Elias L, Blumenstein BA, Kish J, Flanigan RC, Wade JL, Lowe BA, Goodwin JW, Crawford ED.

Cancer. 1996 Sep 1;78(5):1085-8.PMID: 8780547 [PubMed - indexed for MEDLINE]Related articles

Doctor-hospital integrated practice.

Wade JL 3rd.

Oncology (Williston Park). 1996 Jan;10(1):104-6.PMID: 8924361 [PubMed - indexed for MEDLINE]Related articles

Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.

Jones DV Jr, Winn RJ, Brown BW, Levy LB, Pugh RP, Wade JL 3rd, Gross HM, Pendergrass KB, Levin B, Abbruzzese JL.

Cancer. 1995 Nov 15;76(10):1709-14.PMID: 8625038 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.

Albain KS, Liu PY, Hantel A, Poplin EA, O'Toole RV, Wade JL 3rd, Maddox AM, Alberts DS.

Gynecol Oncol. 1995 Jun;57(3):407-11.PMID: 7774846 [PubMed - indexed for MEDLINE]Related articles

Reducing duplicate hand and wrist series in the emergency room: experience at Madigan Army Medical Center.

Wade JL, Youngberg RA, Liss R.

Mil Med. 1995 Jan;160(1):37-8.PMID: 7746432 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.

Moore DF Jr, Pazdur R, Abbruzzese JL, Ajani JA, Dubovsky DW, Wade JL 3rd, Belt RJ, Mangold C, Bready B, Winn RJ.

Ann Oncol. 1994 Mar;5(3):286-7.PMID: 8186177 [PubMed - indexed for MEDLINE]Related articles

Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trial.

Mullane MR, Schilsky RL, Carroll RB, Wade JL 3rd, Kilton LJ, Blough RR, Bauman A, French SL, Benson AB 3rd.

Invest New Drugs. 1994;12(3):267-70.PMID: 7896548 [PubMed - indexed for MEDLINE]Related articles

Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial.

Kilton LJ, Ashenhurst JB, Wade JL 3rd, Schilsky RL, Shiomoto G, Blough RR, French SL, Benson AB 3rd.

Invest New Drugs. 1994;12(2):163-6.PMID: 7532162 [PubMed - indexed for MEDLINE]Related articles

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer.

Cobleigh MA, Dowlatshahi K, Deutsch TA, Mehta RG, Moon RC, Minn F, Benson AB 3rd, Rademaker AW, Ashenhurst JB, Wade JL 3rd, et al.

J Clin Oncol. 1993 Mar;11(3):474-7.PMID: 8445423 [PubMed - indexed for MEDLINE]Related articles

In vivo incorporation of [14C]leucine into brain protein of mice treated with methylmercury and thiol complexes of methylmercury.

Fair PH, Balthrop JE, Wade JL, Braddon-Galloway S.

Toxicol Lett. 1987 May;36(3):213-20.PMID: 3590217 [PubMed - indexed for MEDLINE]Related articles

Mercury distribution studies involving complexes of low-molecular weight thiols and methylmercury.

Balthrop JE, Wade JL, Braddon-Galloway S.

Bull Environ Contam Toxicol. 1986 Dec;37(6):890-8. No abstract available. PMID: 3790762 [PubMed - indexed for MEDLINE]Related articles

Toxicity, distribution, and elimination of thiol complexes of methylmercury after intracerebral injection.

Fair PH, Balthrop JE, Wade JL, Braddon-Galloway S.

J Toxicol Environ Health. 1986;19(2):219-33.PMID: 3761382 [PubMed - indexed for MEDLINE]Related articles

Treatment of malignant pheochromocytoma with combination chemotherapy.

Keiser HR, Goldstein DS, Wade JL, Douglas FL, Averbuch SD.

Hypertension. 1985 May-Jun;7(3 Pt 2):I18-24.PMID: 3997232 [PubMed - indexed for MEDLINE]Related articles

Neurocrest and colonic tumors: new clinical syndrome. Report of three cases.

Wade JL 3rd, Tobin E, Ultmann JE.

Am J Med. 1984 Oct;77(4):725-8.PMID: 6486148 [PubMed - indexed for MEDLINE]Related articles

Operation for diagnosis and treatment of pericardial effusions.

Little AG, Kremser PC, Wade JL, Levett JM, DeMeester TR, Skinner DB.

Surgery. 1984 Oct;96(4):738-44.PMID: 6207601 [PubMed - indexed for MEDLINE]Related articles

Diffuse immunoblastic sarcoma from benign lymphoid proliferation.

Wade JL 3rd, Taylor JR, Ultmann JE.

Ann Intern Med. 1984 May;100(5):765. No abstract available. PMID: 6608894 [PubMed - indexed for MEDLINE]Related articles

Dermal necrosis from dobutamine.

Hoff JV, Peatty PA, Wade JL.

N Engl J Med. 1979 May 31;300(22):1280. No abstract available. PMID: 431702 [PubMed - indexed for MEDLINE]Related articles